Clinical Trial Update: Combination Therapy for BRAF-V600E Metastatic CRCm [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a combination therapy for patients with BRAF-V600E-mutant metastatic colorectal cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Vall d'Hebron Institute of Oncology | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING